Friday, November 26, 2021 10:28:20 PM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964441
Conference call Transcript 11/21
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166906999
A third party overview of Blarcamesine studies
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166423463&txt2find=endoplasmic%20update
Biology concepts for Alzheimer’s disease
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153974885
From MayoMobile
Comments on conference call:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166914257
On Cohen's D:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166914423
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165324944
Commentary for: Functional Significance of Endothelial Sigma-1 Receptors in Vascular Reactivity and Barrier Function:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166857096
On the complexity of the PDD data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165501593
Cantor Healthcare Conference summary:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166133316
AAIC 2021 Updates (ANVS & SAVA) & Anavex’s 29 July 2021 PR
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165176529
Blarcamesine's Overwhelming Phase 2a AD Efficacy: Recap
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164889049
Offline Commentary with Kevindenver
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164851405
SteadyT on Lewy Body
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166840742
Falconer
on the Sociology of Anavex Science:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166911755
COVID-19, autophagy, and the aging process.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166873349
If Fragile X, Then Autism?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166761837
Anavex Mouse studies:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166631928
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166557593
Anti-Aging & Prophylaxis
The Blarcamesine Anti-aging Factor
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166489735
georgejjl On Catalysts and Milestones:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166913317
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166794529
Tempe Phil - Great Expectations:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166810915
boi568 - Confidence in Rett Success
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166839156
sokol- Is amyloyd good or bad?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166563154
A video from Investor2014
Recent AVXL News
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia • GlobeNewswire Inc. • 03/18/2024 11:30:00 AM
- Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference • GlobeNewswire Inc. • 02/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:05:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:32 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:04:31 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM